New injection tested for painful hand and foot blisters

NCT ID NCT03633396

Completed Disease control Sponsor: Vanda Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study tested whether an experimental drug called ANB019 (imsidolimab) could reduce painful blisters and scaling on the palms and soles in adults with palmoplantar pustulosis. 59 participants received either the drug or a placebo injection to compare safety and effectiveness over 16 weeks. The goal was to see if the treatment could better control this chronic skin condition compared to no active treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Investigational Site

Birmingham, Alabama, 35233, United States
Investigational Site

Phoenix, Arizona, 85032, United States
Investigational Site

Encino, California, 91436, United States
Investigational Site

Santa Monica, California, 90405, United States
Investigational Site

Fort Lauderdale, Florida, 33316, United States
Investigational Site

Miami, Florida, 33155, United States
Investigational Site

Pembroke Pines, Florida, 33028, United States
Investigational Site

Tampa, Florida, 33607, United States
Investigational Site

Indianapolis, Indiana, 46250, United States
Investigational Site

Plainfield, Indiana, 46168, United States
Investigational Site

Overland Park, Kansas, 66215, United States
Investigational Site

Ann Arbor, Michigan, 48109, United States
Investigational Site

St Louis, Missouri, 63110, United States
Investigational Site

St Louis, Missouri, 63117, United States
Investigational Site

Wilmington, North Carolina, 28405, United States
Investigational Site

Columbus, Ohio, 43230, United States
Investigational Site

Norman, Oklahoma, 73071, United States
Investigational Site

Portland, Oregon, 97239, United States
Investigational Site

Dallas, Texas, 75230, United States
Investigational Site

Surrey, British Columbia, Canada
Investigational Site

Greater Sudbury, Ontario, Canada
Investigational Site

Markham, Ontario, Canada
Investigational Site

Drummondville, Quebec, Canada
Investigational Site

Montreal, Quebec, Canada
Investigational Site

Bad Bentheim, 48455, Germany
Investigational Site

Berlin, 10117, Germany
Investigational Site

Berlin, 10789, Germany
Investigational Site

Bonn, 53127, Germany
Investigational Site

Hamburg, 20253, Germany
Investigational Site

Hamburg, 22391, Germany
Investigational Site

Schwerin, 19055, Germany
Investigational Site

Gdansk, 80-546, Poland
Investigational Site

Katowice, 40-611, Poland
Investigational Site

Lodz, 90-265, Poland
Investigational Site

Olsztyn, 10-229, Poland
Investigational Site

Ostrowiec Świętokrzyski, 27-400, Poland
Investigational Site

Rzeszów, 35-055, Poland
Investigational Site

Szczecin, 70-332, Poland
Investigational Site

Wroclaw, 50-566, Poland

Conditions

Explore the condition pages connected to this study.

PALMOPLANTAR PUSTULOSIS